Plus: Shares in several major banks fall after federal regulators raise concerns about their wind-down plans. Shares in Sarepta Therapeutics jump after its new muscular dystrophy gene therapy receives approval. And Nikola’s stock rises after the embattled EV maker’s board approves a reverse stock split. Danny Lewis hosts.
Sign up for the WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices